EA201590903A1 - Применение и режим приема фармацевтической композиции, содержащей левоноргестрел и ингибитор цог, для контрацепции по мере необходимости ("on-demand") - Google Patents

Применение и режим приема фармацевтической композиции, содержащей левоноргестрел и ингибитор цог, для контрацепции по мере необходимости ("on-demand")

Info

Publication number
EA201590903A1
EA201590903A1 EA201590903A EA201590903A EA201590903A1 EA 201590903 A1 EA201590903 A1 EA 201590903A1 EA 201590903 A EA201590903 A EA 201590903A EA 201590903 A EA201590903 A EA 201590903A EA 201590903 A1 EA201590903 A1 EA 201590903A1
Authority
EA
Eurasian Patent Office
Prior art keywords
contraception
demand
inhibitor
organester
leono
Prior art date
Application number
EA201590903A
Other languages
English (en)
Inventor
Бернхард Линденталь
Катрин Вэльнитц
Петер Зерно
Штефани Линдеманн
Ульрике Фурманн
Original Assignee
Байер Фарма Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49585417&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201590903(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Байер Фарма Акциенгезельшафт filed Critical Байер Фарма Акциенгезельшафт
Publication of EA201590903A1 publication Critical patent/EA201590903A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение касается способа гормональной женской контролируемой контрацепции по мере необходимости ("On-Demand"), в котором фармацевтический препарат, содержащий ингибитор ЦОГ и левоноргестрел, принимают по мере необходимости перед ожидаемым половым актом. Изобретение также касается фармацевтических композиций и режима приема для контрацепции по мере необходимости.
EA201590903A 2012-11-22 2013-11-19 Применение и режим приема фармацевтической композиции, содержащей левоноргестрел и ингибитор цог, для контрацепции по мере необходимости ("on-demand") EA201590903A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12193725 2012-11-22
EP13186133 2013-09-26
PCT/EP2013/074167 WO2014079840A1 (de) 2012-11-22 2013-11-19 Verwendung und anwendungsregime einer pharmazeutischen zusammensetzung enthaltend levonorgestrel und einen cox-inhibitor zur bedarfsweisen ("on-demand") kontrazeption

Publications (1)

Publication Number Publication Date
EA201590903A1 true EA201590903A1 (ru) 2015-11-30

Family

ID=49585417

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201590903A EA201590903A1 (ru) 2012-11-22 2013-11-19 Применение и режим приема фармацевтической композиции, содержащей левоноргестрел и ингибитор цог, для контрацепции по мере необходимости ("on-demand")

Country Status (19)

Country Link
US (1) US9579330B2 (ru)
EP (1) EP2922552A1 (ru)
JP (1) JP6254605B2 (ru)
KR (1) KR20150085512A (ru)
CN (1) CN104797258A (ru)
AP (1) AP2015008437A0 (ru)
AU (1) AU2013349776A1 (ru)
BR (1) BR112015011212A2 (ru)
CA (1) CA2891854A1 (ru)
CL (1) CL2015001368A1 (ru)
EA (1) EA201590903A1 (ru)
HK (1) HK1207588A1 (ru)
IL (1) IL238767A0 (ru)
MX (1) MX2015006499A (ru)
PH (1) PH12015501110A1 (ru)
SG (1) SG11201503275RA (ru)
TN (1) TN2015000197A1 (ru)
TW (1) TW201420103A (ru)
WO (1) WO2014079840A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG177284A1 (en) 2009-06-23 2012-02-28 Bayer Pharma AG Pharmaceutical composition for emergency contraception
WO2022225986A1 (en) * 2021-04-19 2022-10-27 Archer David Fitzgerald On demand female contraceptive

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4576063A (en) 1982-02-27 1986-03-18 Toyota Jidosha Kabushiki Kaisha Transmission mechanism with parallel transmission systems including one way clutches, one being lockable
EP0520119A1 (de) 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Neue orale Diclofenaczubereitung
TW358031B (en) 1997-04-11 1999-05-11 Akze Nobel N V Drug delivery system for 2 or more active substances
HU227198B1 (en) 2001-11-27 2010-10-28 Richter Gedeon Nyrt Pharmaceutical composition for emergency contraception containing levonorgestrel
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
DE102005050729A1 (de) 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
CA2758764C (en) * 2009-04-14 2017-04-11 Elizabeth Gray Raymond Method for on-demand contraception using levonorgestrel or norgestrel
PL2419108T3 (pl) * 2009-04-14 2017-08-31 Laboratoire Hra Pharma Sposób antykoncepcji na żądanie
SG177284A1 (en) * 2009-06-23 2012-02-28 Bayer Pharma AG Pharmaceutical composition for emergency contraception

Also Published As

Publication number Publication date
MX2015006499A (es) 2015-08-14
CL2015001368A1 (es) 2015-07-24
SG11201503275RA (en) 2015-06-29
BR112015011212A2 (pt) 2017-07-11
JP6254605B2 (ja) 2017-12-27
EP2922552A1 (de) 2015-09-30
US9579330B2 (en) 2017-02-28
AU2013349776A1 (en) 2015-05-28
PH12015501110A1 (en) 2015-08-10
CN104797258A (zh) 2015-07-22
WO2014079840A1 (de) 2014-05-30
TW201420103A (zh) 2014-06-01
AP2015008437A0 (en) 2015-05-31
CA2891854A1 (en) 2014-05-30
KR20150085512A (ko) 2015-07-23
TN2015000197A1 (en) 2016-10-03
IL238767A0 (en) 2015-06-30
US20160000805A1 (en) 2016-01-07
JP2016500087A (ja) 2016-01-07
HK1207588A1 (en) 2016-02-05

Similar Documents

Publication Publication Date Title
EA201200029A1 (ru) Фармацевтическая композиция для экстренной контрацепции
EA201291372A1 (ru) Фармацевтическая композиция, содержащая дроспиренон, и набор для предупреждения зачатия
EA201591003A1 (ru) Производные бороновой кислоты и их терапевтическое применение
CO6690768A2 (es) Derivados de triazina-oxadiazoles, útiles como inhibidores de los canales de sodio navi.7
BR112015022096A8 (pt) compostos moduladores de canal de sódio, composição que os compreende e uso dos mesmos
CY1118996T1 (el) Χρηση οιστετρολης ως αντισυλληπτικο επειγουσας καταστασης
BR112014010290B8 (pt) Composição farmacêutica na forma de dispersão sólida de ativos específicos em polímeros específicos e uso da composição farmacêutica
MX340985B (es) Compuestos de n-heteroarilo.
EA201490395A1 (ru) Способ получения фармацевтических композиций, содержащих финголимод
MX2019005082A (es) Composiciones que comprenden 15-ohepa y metodos para usar las mismas.
EA201490653A1 (ru) Производные эстра-1,3,5(10),16-тетраен-3-карбоксамида, способ их получения, содержащие их фармацевтические препараты, а также их применение для получения лекарственных средств
EA201490222A1 (ru) Комбинированные составы на основе дарунавира
EA201500851A1 (ru) ЭСТРА-1,3,5(10),16-ТЕТРАЕН-3-КАРБОКСАМИДЫ ДЛЯ ИНГИБИРОВАНИЯ 17β-ГИДРОКСИСТЕРОИД-ДЕГИДРОГЕНАЗЫ (AKR1C3)
EA201591196A1 (ru) Композиции и способы для трансдермальной доставки гормонов и других лекарственных средств
EA201490223A1 (ru) Составы на основе дарунавира
BR112013025696A2 (pt) composição compreendendo cimento portland para utilização em vertebroplastia
EA201400064A1 (ru) Офтальмологическая фармацевтическая композиция для местного применения, которая содержит регорафениб
EA201590903A1 (ru) Применение и режим приема фармацевтической композиции, содержащей левоноргестрел и ингибитор цог, для контрацепции по мере необходимости ("on-demand")
EA201491614A1 (ru) Способ лечения гинекологических заболеваний
MX359887B (es) Composicion masticable para administracion oral y proceso para preparar la misma.
EA201492238A1 (ru) Композиция мизопростола
PH12015502598A1 (en) Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception
GT201400044A (es) 2-(croman-6-iloxi)-tiazoles sustituidos y su uso como productos farmacéuticos
MX359106B (es) Composicion farmaceutica inyectable de dexketoprofeno y tramadol.
MA20150397A1 (fr) Utilisation et schémas posologiques d'application d'une composition pharmaceutique contenant du lévonorgestrel et un inhibiteur de cox pour la contraception à la demande